The Claim
Creatine supplementation enhances the activation and tumor antigen-specific T cell priming capacity of human monocyte-derived dendritic cells in vitro.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Creatine supplementation increases the ability of human dendritic cells derived from monocytes to activate T cells that recognize tumor antigens in laboratory cell cultures.
See the scientific wording
Creatine supplementation enhances the activation and tumor antigen-specific T cell priming capacity of human monocyte-derived dendritic cells in vitro, suggesting potential translational relevance for human cancer immunotherapy.
Dendritic cells take in creatine when they are activated, convert it into a storage form that holds energy, and use that stored energy to keep their power supply stable. This stable power allows them to keep turning on a key signaling system that makes them more active and better at alerting T cells to attack cancer cells. As a result, the T cells multiply more, release more attack signals, and become more effective at finding and killing tumor cells.
What the research says
1 studyStudy: Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
Adding creatine to human immune cells in the lab made them better at teaching T cells to recognize and attack cancer cells, just like the claim says. This suggests creatine might help improve cancer immunotherapy.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.